Form 4: Fulgent Genetics CFO Sells Shares for Tax Obligations

Fulgent Genetics' CFO, Paul Kim, disposed of 670 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Summary

• Paul Kim, Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported a transaction on August 23, 2025.
• The transaction involved the disposition of 670 shares of Fulgent Genetics common stock at a price of $21.77 per share.
• These shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted to Mr. Kim on February 23, 2023.
• Following this transaction, Paul Kim beneficially owns 339,158 shares of Fulgent Genetics common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding upon RSU vesting, which is a neutral event for the company's operational or financial outlook.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This routine insider transaction, specifically a tax withholding related to RSU vesting, does not provide direct insights into broader industry trends or competitive positioning for Fulgent Genetics.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's confidence or a significant shift in ownership.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such a transaction does not provide new fundamental information about the company's performance, strategy, or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining any existing investment thesis.

Keywords

Fulgent Genetics, FLGT, Paul Kim, CFO, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding